Close

PhaseBio Pharmaceuticals Inc. (PHAS) Reports Publication of Full Results from Phase 1 Clinical Trial of PB2452 in New England Journal of Medicine

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/23/2024

1. TSLA
2. GM
3. SPY
4. SHW
5. SPOT
6. AMZN
7. AAPL
8. NVDA
9. MINN
10. MTTR


Go back to PhaseBio Pharmaceuticals Inc. (PHAS) Reports Publication of Full Results from Phase 1 Clinical Trial of PB2452 in New England Journal of Medicine
(NASDAQ: PHAS) Delayed: 0.07 --0 (-0%)
Previous Close $0.07    52 Week High $ 
Open $0.07    52 Week Low $ 
Day High $0.07    P/E N/A 
Day Low $0.07    EPS $ 
Volume 2,000,067